US 12,220,490 B2
Adhesive patch containing an improved release liner system
Ravi Ramjit, Dix Hills, NY (US); Michael Talian, Northvale, NJ (US); and Semyon Itskovich, Fair Lawn, NJ (US)
Assigned to EUROMED, INC., Orangeburg, NY (US)
Appl. No. 16/474,866
Filed by EUROMED, INC., Orangeburg, NY (US)
PCT Filed Dec. 29, 2017, PCT No. PCT/US2017/069007
§ 371(c)(1), (2) Date Jun. 28, 2019,
PCT Pub. No. WO2018/126170, PCT Pub. Date Jul. 5, 2018.
Claims priority of provisional application 62/440,966, filed on Dec. 30, 2016.
Prior Publication US 2019/0350873 A1, Nov. 21, 2019
Int. Cl. A61K 9/70 (2006.01); A61F 13/00 (2024.01); A61F 13/02 (2006.01); A61P 17/10 (2006.01); B32B 37/12 (2006.01); B32B 38/10 (2006.01); C09J 7/21 (2018.01); C09J 7/22 (2018.01); C09J 7/30 (2018.01); C09J 7/40 (2018.01); C09J 109/06 (2006.01); C09J 125/10 (2006.01)
CPC A61K 9/7046 (2013.01) [A61F 13/00063 (2013.01); A61F 13/00076 (2013.01); A61F 13/00085 (2013.01); A61F 13/0259 (2013.01); A61K 9/703 (2013.01); A61K 9/7038 (2013.01); A61K 9/7053 (2013.01); A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61P 17/10 (2018.01); B32B 37/12 (2013.01); B32B 38/10 (2013.01); C09J 7/21 (2018.01); C09J 7/22 (2018.01); C09J 7/30 (2018.01); C09J 7/40 (2018.01); C09J 109/06 (2013.01); C09J 125/10 (2013.01); A61F 2013/00582 (2013.01); A61F 2013/00812 (2013.01); C09J 2301/408 (2020.08)] 18 Claims
OG exemplary drawing
 
1. A flexible adhesive patch arrangement comprising in the following order:
a flexible adhesive patch comprising:
a backing having two sides, wherein the backing is continuous without perforations or indentations; and
a therapeutic adhesive composition coated on at least a portion of one side of the backing, wherein the therapeutic adhesive composition is capable of adhering to mammalian skin; and
a liner completely covering the therapeutic adhesive composition, wherein the liner contains a means for readily separating the liner into two portions, with each portion being in contact with the therapeutic adhesive composition;
wherein an area of the liner is larger than an area of the adhesive composition;
wherein each of the backing and the therapeutic adhesive composition has a circular or oval shape; and
wherein the backing has a diameter of 0.2 inches to 0.5 inches.